7081 PHARMA | Malaysia
PHARMANIAGA BHD
RM 0.845 on: 2021-07-27
-3.98% Past 1-day return
-3.98% Past 5-day return
Price/Valuation Analysis
Current Price Status
-
Stock in Weak Growth Expectation
Stock is currently in distressed situation that the market is pricing a worse than industry average negative annual earning growth.
Stock in this situation can be good bargain if the stock beats the weak growth expectation or it can be long-term downtrend if the weak earning growth remains for a while. -
Company is in Positive Earning
Fair Value
- PHARMA current price is 32.54% below OneDelta estimated fair value.
-
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
-
Underperformed
PHARMA past 5-day return lagged behind the Pharmaceuticals industry average return by 3.21% -
Below 30-Day Average
Current price RM0.845 is below 30-day average RM2.95 by 249.1%
| Return (%) | PHARMA | Pharmaceuticals |
|---|---|---|
| 1-Day | -3.98% | -0.71% |
| 5-Day | -3.98% | -0.77% |
| 30-Day | -83.62% | -11.46% |
Bank Analyst Price Targets
HOLD
RM 1.10
SELL
RM 2.50
Revenue & Earning Growth Analysis
-
Cyclical Revenue Growth
PHARMA recorded various revenue growth in different quarters with no clear growth direction.
-
Unstable Profit Growth
PHARMA has been experiencing substantial ups and downs on profit growth.
Past Quarter Reports
| Quarter Date | Revenue (RM) | (%) | EPS (RM) | (%) |
|---|---|---|---|---|
| 2020-12-31 | 634,583k | +2% | -0.0242 | 0% |
| 2020-09-30 | 624,804k | -3% | 0.0055 | -86% |
| 2020-06-30 | 645,763k | -21% | 0.0382 | -55% |
| 2020-03-31 | 819,921k | +15% | 0.0857 | 0% |
| 2019-12-31 | 715,683k | -0% | -0.6845 | 0% |
Volume Trend Analysis
-
Recent Volume is Increasing
Surge in trading volume tends to bring more price volatility in near term.
-
PHARMA recent daily traded volume is 1.94% higher than past month average.
| Past 30-Day | Past 5-Day |
|---|---|
| 103k daily | 105k daily |
Financials
Price History Chart
Past 30-day Average Price: RM2.95
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Stock Thematic Baskets
Usually the more the stock is included in popular themes, the more opportunity for price-driven momentum and better liquidity.
Market News & Investor Opinions
290,480 vials of Sinovac vaccine bottled by Pharmaniaga to be used from today
Pharmaniaga rises as much as 20.4% on bonus issue
Pharmaniaga proposes four-for-one bonus issue
Healthy outlook for Duopharma Biotech
Duopharma rises on strong earnings
Duopharma says 1Q net profit rises 30% on higher sales, proposes bonus issue
Duopharma posts higher Q1 net profit, vaccine deal to boost FY21 earnings
Duopharma earnings soar, plans bonus issue
CGS-CIMB Research upgrades Duopharma to add, TP RM3.67
Duopharma's bullish momentum to continue
Stock Company Profile
PHARMANIAGA BHD
Pharmaniaga Bhd. is an investment holding company. It engages in the research & development, manufacturing of generic pharmaceutical products, sales & marketing as well as logistics and distribution of pharmaceutical products & medical equipment. The firm operates through the following segments: Logistics and Distribution, Manufacturing, and Indonesia. The Logistics and Distribution segment engages in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Manufacturing segment manufactures pharmaceutical products in Malaysia. The Indonesia segment manufactures and distributes pharmaceutical and medical products in Indonesia. The company was founded on August 21, 1998 and is headquartered in Shah Alam, Malaysia.